Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Monoclonal antibodies are a special type of antibody that is created in the laboratory to find and destroy a specific target, in this case cancer. Because of their accuracy, it is desirable to treat tumors with monoclonal antibodies more specifically than chemotherapeutic drugs, and therefore with fewer side effects. In health care, cancer is one of the biggest concerns. Therefore, monoclonal antibodies are increasingly used to treat cancer.
North America is expected to hold a significant share in the Cancer Monoclonal Antibodies market. The cancer monoclonal antibodies market is expected to witness a CAGR of 10% during the forecast period, 2020-2026.
The growing prevalence of cancer, increasing investment in R&D of genomic studies, and rising advancements in the specificity of monoclonal antibodies to target cancer are the factors to drive the Cancer Monoclonal Antibodies market. However, long duration of research and development before clinical trials and the rise in the failures of mAbs in clinical trials may hinder the growth of the cancer monoclonal antibodies market.
The report details the trend, potential and market size of Cancer Monoclonal Antibodies market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Cancer Monoclonal Antibodiesmarket, defines the market attractiveness level of Cancer Monoclonal Antibodies market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Cancer Monoclonal Antibodies industry, describes the types of Cancer Monoclonal Antibodies market, the applications of major players and the market size, and deeply analyzes the current situation of the global Cancer Monoclonal Antibodies market and the development prospects and opportunities of Cancer Monoclonal Antibodies industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Cancer Monoclonal Antibodies market in Chapter 13.
By Player:
F Hoffmann-La Roche
Takeda Pharmaceuticals
Bristol-Myers Squibb
Amgen
By Type:
Murine Antibodies
Chimeric and Humanised Antibodies
Fully Humanized Antibodies
Others
By End-User:
Breast Cancer
Blood Cancer
Liver Cancer
Brain Cancer
Colorectal Cancer
Other Applications
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Cancer Monoclonal Antibodies Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Cancer Monoclonal Antibodies Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Cancer Monoclonal Antibodies Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Cancer Monoclonal Antibodies Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Cancer Monoclonal Antibodies Market Analysis and Outlook to 2022
-
7.1 Global Cancer Monoclonal Antibodies Consumption (2017-2022)
-
7.2 United States Cancer Monoclonal Antibodies Consumption (2017-2022)
-
7.3 Europe Cancer Monoclonal Antibodies Consumption (2017-2022)
-
7.4 China Cancer Monoclonal Antibodies Consumption (2017-2022)
-
7.5 Japan Cancer Monoclonal Antibodies Consumption (2017-2022)
-
7.6 India Cancer Monoclonal Antibodies Consumption (2017-2022)
-
7.7 South Korea Cancer Monoclonal Antibodies Consumption (2017-2022)
8 Region and Country-wise Cancer Monoclonal Antibodies Market Analysis and Outlook to 2028
-
8.1 Global Cancer Monoclonal Antibodies Consumption Forecast (2022-2028)
-
8.2 United States Cancer Monoclonal Antibodies Consumption Forecast (2022-2028)
-
8.3 Europe Cancer Monoclonal Antibodies Consumption Forecast (2022-2028)
-
8.4 China Cancer Monoclonal Antibodies Consumption Forecast (2022-2028)
-
8.5 Japan Cancer Monoclonal Antibodies Consumption Forecast (2022-2028)
-
8.6 India Cancer Monoclonal Antibodies Consumption Forecast (2022-2028)
-
8.7 South Korea Cancer Monoclonal Antibodies Consumption Forecast (2022-2028)
9 Global Cancer Monoclonal Antibodies Market Outlook by Types and Applications to 2022
-
9.1 Global Cancer Monoclonal Antibodies Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Murine Antibodies Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Chimeric and Humanised Antibodies Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Fully Humanized Antibodies Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Cancer Monoclonal Antibodies Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Breast Cancer Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Blood Cancer Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Liver Cancer Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Brain Cancer Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Colorectal Cancer Consumption and Growth Rate (2017-2022)
-
9.2.6 Global Other Applications Consumption and Growth Rate (2017-2022)
10 Global Cancer Monoclonal Antibodies Market Outlook by Types and Applications to 2028
-
10.1 Global Cancer Monoclonal Antibodies Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Murine Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Chimeric and Humanised Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Fully Humanized Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Cancer Monoclonal Antibodies Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Blood Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Liver Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Brain Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Colorectal Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.6 Global Other Applications Consumption Forecast and Growth Rate (2022-2028)
11 Global Cancer Monoclonal Antibodies Import and Export Analysis (Top 5 Countries)
-
11.1 Global Cancer Monoclonal Antibodies Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Cancer Monoclonal Antibodies Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Cancer Monoclonal Antibodies Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Cancer Monoclonal Antibodies Market Competitive Analysis
-
14.1 F Hoffmann-La Roche
-
14.1.1 F Hoffmann-La Roche Company Details
-
14.1.2 F Hoffmann-La Roche Cancer Monoclonal Antibodies Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 F Hoffmann-La Roche Cancer Monoclonal Antibodies Product and Service
-
14.2 Takeda Pharmaceuticals
-
14.2.1 Takeda Pharmaceuticals Company Details
-
14.2.2 Takeda Pharmaceuticals Cancer Monoclonal Antibodies Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Takeda Pharmaceuticals Cancer Monoclonal Antibodies Product and Service
-
14.3 Bristol-Myers Squibb
-
14.3.1 Bristol-Myers Squibb Company Details
-
14.3.2 Bristol-Myers Squibb Cancer Monoclonal Antibodies Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Bristol-Myers Squibb Cancer Monoclonal Antibodies Product and Service
-
14.4 Amgen
-
14.4.1 Amgen Company Details
-
14.4.2 Amgen Cancer Monoclonal Antibodies Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Amgen Cancer Monoclonal Antibodies Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Cancer Monoclonal Antibodies
-
Figure Cancer Monoclonal Antibodies Picture
-
Table Global Cancer Monoclonal Antibodies Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Cancer Monoclonal Antibodies Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Cancer Monoclonal Antibodies Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Cancer Monoclonal Antibodies Consumption by Country (2017-2022)
-
Figure United States Cancer Monoclonal Antibodies Consumption and Growth Rate (2017-2022)
-
Table Europe Cancer Monoclonal Antibodies Consumption and Growth Rate (2017-2022)
-
Figure China Cancer Monoclonal Antibodies Consumption and Growth Rate (2017-2022)
-
Figure Japan Cancer Monoclonal Antibodies Consumption and Growth Rate (2017-2022)
-
Figure India Cancer Monoclonal Antibodies Consumption and Growth Rate (2017-2022)
-
Figure South Korea Cancer Monoclonal Antibodies Consumption and Growth Rate (2017-2022)
-
Figure Global Cancer Monoclonal Antibodies Consumption Forecast by Country (2022-2028)
-
Figure United States Cancer Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Cancer Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Cancer Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Cancer Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Cancer Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Cancer Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Murine Antibodies Consumption and Growth Rate (2017-2022)
-
Figure Global Chimeric and Humanised Antibodies Consumption and Growth Rate (2017-2022)
-
Figure Global Fully Humanized Antibodies Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Breast Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Blood Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Liver Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Brain Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Colorectal Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Other Applications Consumption and Growth Rate (2017-2022)
-
Figure Global Murine Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Chimeric and Humanised Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Fully Humanized Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Blood Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Liver Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Brain Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Colorectal Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Applications Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Cancer Monoclonal Antibodies Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Cancer Monoclonal Antibodies Export by Region (Top 5 Countries) (2017-2028)
-
Table F Hoffmann-La Roche (Foundation Year, Company Profile and etc.)
-
Table F Hoffmann-La Roche Cancer Monoclonal Antibodies Sales, Price, Value and Gross Profit (2017-2022)
-
Table F Hoffmann-La Roche Cancer Monoclonal Antibodies Product and Service
-
Table Takeda Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Takeda Pharmaceuticals Cancer Monoclonal Antibodies Sales, Price, Value and Gross Profit (2017-2022)
-
Table Takeda Pharmaceuticals Cancer Monoclonal Antibodies Product and Service
-
Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Cancer Monoclonal Antibodies Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Cancer Monoclonal Antibodies Product and Service
-
Table Amgen (Foundation Year, Company Profile and etc.)
-
Table Amgen Cancer Monoclonal Antibodies Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Cancer Monoclonal Antibodies Product and Service
-
